scholarly journals Fulminant type 1 diabetes in an elderly patient treated after receiving a diagnosis of type 2 diabetes

2013 ◽  
Vol 50 (6) ◽  
pp. 818-823 ◽  
Author(s):  
Akiko Ogawa ◽  
Tetsuji Niiya ◽  
Kenichi Manabe ◽  
Eriko Kawamoto
2017 ◽  
Vol 26 (2) ◽  
pp. 147-150
Author(s):  
Ji Min Kim ◽  
Ji Hye Han ◽  
Kyong Hye Joung ◽  
Ju Hee Lee ◽  
Hyun Jin Kim ◽  
...  

2010 ◽  
Vol 43 (15) ◽  
pp. 1265-1267 ◽  
Author(s):  
Masafumi Koga ◽  
Jun Murai ◽  
Hiroshi Saito ◽  
Mikio Mukai ◽  
Soji Kasayama ◽  
...  

2015 ◽  
Vol 16 (3) ◽  
pp. 225
Author(s):  
Seung Min Woo ◽  
Seung Hyun Hong ◽  
Sung Yun Lee ◽  
Su Heui Lee ◽  
Duc Ky Lee ◽  
...  

2012 ◽  
Vol 3 ◽  
pp. JCM.S9509
Author(s):  
Akitsu Kawabe ◽  
Takashi Seta ◽  
Sumie Fujii ◽  
Masayo Yamada ◽  
Shogo Oki ◽  
...  

Fulminant type 1 diabetes mellitus (FT1DM) develops as a result of very rapid and almost complete destruction of pancreatic β cells. Because of an abrupt increase in plasma glucose, HbA1c and glycated albumin (GA) might increase along with duration of symptoms in FT1DM patients. We attempted to devise a formula to estimate duration of symptoms based on the increased levels in HbA1c or GA. Four patients who developed FT1DM during the course of type 2 diabetes mellitus and in whom HbA1c was measured before onset were investigated in this study. The percents of the estimated duration of symptoms calculated from HbA1c (four patients) and GA (two patients) to the actual duration were 137 ± 88% and 122%, respectively. In FT1DM patients in whom HbA1c and/or GA before onset and at the time of ketoacidosis are measured, duration of symptoms might be estimated with using the increased levels in HbA1c or GA.


2017 ◽  
Author(s):  
Marwa Omri ◽  
Rayene Ben Mohamed ◽  
Imen Rezgani ◽  
Sana Mhidhi ◽  
Aroua Temessek ◽  
...  

2008 ◽  
Vol 70 (5) ◽  
pp. 482-486
Author(s):  
Ikko KAJIHARA ◽  
Asako ICHIHARA ◽  
Jyunko HIGO ◽  
Masato KIDOU ◽  
Mikio TODAKA ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document